PERRIGO
Prostatype Genomics AB manufactures, markets, and sells the prognostic gene tests. It offers Prostatype Test System that combines gene expression information with used clinical parameters, such as PSA, Gleason Score, and Tumor Stage, as well as calculates the P-score. The company's test is based on database containing prostate cancer patients, as well as provides decision support for patients and… Read more
PERRIGO (PGO) - Total Assets
Latest total assets as of June 2024: €32.27 Million EUR
Based on the latest financial reports, PERRIGO (PGO) holds total assets worth €32.27 Million EUR as of June 2024.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
PERRIGO - Total Assets Trend (2019–2024)
This chart illustrates how PERRIGO’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
PERRIGO - Asset Composition Analysis
Current Asset Composition (June 2024)
PERRIGO's total assets of €32.27 Million consist of 52.6% current assets and 47.4% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 5.5% |
| Accounts Receivable | €213.00K | 0.4% |
| Inventory | €203.00K | 0.4% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €23.18 Million | 47.1% |
| Goodwill | €0.00 | 0.0% |
Asset Composition Trend (2019–2024)
This chart illustrates how PERRIGO's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: PERRIGO's current assets represent 52.6% of total assets in 2024, an increase from 25.5% in 2019.
- Cash Position: Cash and equivalents constituted 5.5% of total assets in 2024, down from 15.3% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 47.0% of total assets, a decrease from 74.0% in 2019.
- Asset Diversification: The largest asset category is intangible assets at 47.1% of total assets.
PERRIGO Competitors by Total Assets
Key competitors of PERRIGO based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
ADCNF
OTCGREY:ADCNF
|
USA | $4.51 Billion |
|
Berry Genomics Co Ltd
SHE:000710
|
China | CN¥2.34 Billion |
|
Malaysian Genomics Resource
KLSE:0155
|
Malaysia | RM20.70 Million |
|
NSN Co. Ltd
KQ:031860
|
Korea | ₩60.96 Billion |
|
JOONGANG DNM Co.Ltd
KQ:051980
|
Korea | ₩121.79 Billion |
|
GeneMatrix Inc
KQ:109820
|
Korea | ₩28.03 Billion |
|
Genoray Co. Ltd
KQ:122310
|
Korea | ₩125.67 Billion |
|
Green Cross Lab Cell Corporation
KQ:144510
|
Korea | ₩565.79 Billion |
PERRIGO - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - PERRIGO generates 0.03x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - PERRIGO is currently not profitable relative to its asset base.
PERRIGO - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.17 | 2.72 | 4.89 |
| Quick Ratio | 0.16 | 2.69 | 4.85 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €-15.81 Million | € 9.55 Million | € 17.63 Million |
PERRIGO - Advanced Valuation Insights
This section examines the relationship between PERRIGO's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.82 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 59.0% |
| Total Assets | €49.22 Million |
| Market Capitalization | $6.37K USD |
Valuation Analysis
Below Book Valuation: The market values PERRIGO's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: PERRIGO's assets grew by 59.0% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for PERRIGO (2019–2024)
The table below shows the annual total assets of PERRIGO from 2019 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-06-30 | €49.22 Million | +59.04% |
| 2023-06-30 | €30.95 Million | -23.01% |
| 2022-06-30 | €40.20 Million | +128.76% |
| 2019-06-30 | €17.57 Million | -- |